Mitaban Recall

Get an alert when a recall is issued.

Questions & Answers

Side Effects & Adverse Reactions

  • Please refer to warning at beginning of the package insert.
  • Not for human use. Keep out of reach of children.
  • MITABAN (amitraz) may be harmful if swallowed by humans. If swallowed, do not induce vomiting (contains xylol) and immediately call a physician. Avoid inhalation of vapors (xylol) and contamination of feed and food stuffs.
  • MITABAN is flammable; when diluted with water, the mixture is not flammable.
  • MITABAN (concentrate or diluted) may cause eye or skin irritation in sensitive persons. Do not get in eyes, on skin or on clothing. If in eyes, wash with water for 15 minutes and call a physician immediately.
  • Protect exposed skin (e.g. with rubber gloves, etc.) when mixing MITABAN with water and treating animals. Wash hands and arms with soap and water after treatment of the pet(s). Dispose of unused MITABAN-water solution by flushing down the drain. Rinse the MITABAN container with water and do not reuse.
  • Avoid handling pets immediately after treatment. Contact may cause skin irritation in sensitive individuals during the first few days after treatment.
  • Amitraz, the active ingredient in MITABAN, has been shown to cause liver tumors in female mice.
  • Ingestion or inhalation may cause central nervous system depression.
  • The Material Safety Data Sheet (MSDS) for Mitaban contains more detailed occupational safety information. To obtain a MSDS please call 1-800-733-5500.
  • To report an adverse reaction please call 1-800-366-5288.

Legal Issues

There is currently no legal information available for this drug.

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.


There is currently no usage information available for this product. We apologize for any inconvenience.


There is currently no drug history available for this drug.

Other Information

MITABAN (amitraz) Liquid Concentrate contains 19.9% N'-(2,4 dimethylphenyl)- N-[[(2,4-dimethylphenyl)imino]methyl]-N-methylmethanimidamide (w/w), and also xylol, propylene oxide, and a blend of alkyl benzene sulfonates and exthoxylated polyethers. Amitraz, a diamide, is pale yellow, has a melting point of 86° to 87° C, is not hygroscopic, is stable to heating, soluble in most organic solvents, and sparingly soluble in water.

Mitaban Manufacturers

  • Pharmacia And Upjohn Company
    Mitaban (Amitraz) Liquid [Pharmacia And Upjohn Company]
  • Zoetis Inc.
    Mitaban (Amitraz) Liquid [Zoetis Inc.]

Login To Your Free Account